COLY Still selling for cash, $95M, just licensed their tech nonexclusively to DVAX for the Hep B vaccine for $5M + milestones + royalties. <A HREF="http://biz.yahoo.com/prnews/070628/neth097.html?.v=11" target="_blank">http://biz.yahoo.com/prnews/070628/neth097.html?.v=11</A>